Background. We have previously shown that interstitial plaque particles appear first in the basement membranes of thin loops of Henle and then in the interstitial space. However, it is not known if the plaque in the basement membrane of thin loops of Henle is of the same or different form than the interstitial plaque. Thus our purpose here is to detail the structure of the interstitial and membrane-bound plaque and explore the relationship of plaque apatite to osteopontin, a well-known crystal-associated urine protein.
apatite crystal per se. However, our findings clearly show osteopontin is one of the crystal-associated urine proteins involved in the formation of the organic layers of the plaque particles.
Elsewhere [1] we have shown that interstitial apatite plaque particles appear to first form in the basement membranes of the thin loops of Henle. In addition, we have shown that plaque formation appears related to water conservation, hypercalciuria, and an acid urine pH [2] , as one might expect if plaque originated because of supersaturations with respect to calcium phosphate in thin limb lumens or renal papillary interstitium [3] . For many years, apatite plaque has been considered as a potential surface on which calcium oxalate might grow to form a renal stone [4] . A reasonable formulation at the present time would presume plaque forms in thin limb basement membranes, and expands its range through the papillary interstitium, eventually reaching the suburothelial compartment, perhaps breaching the urothelium, and presenting its surface to the final urine.
Many elements of this general hypothetic mechanism for stone pathogenesis are at present incompletely specified. In particular, the detailed structure of plaque particles is known only superficially. Whether plaque in the thin limb basement membranes and in the papillary interstitium is of the same or different form is not as yet known. Especially important is the nature of the molecules that associate with the apatite in plaque. Urine, for example, contains many molecules that bind to calcium crystals and can affect crystallization [5] [6] [7] [8] [9] ; some or all of these may associate with plaque. Our purpose here is to present the detailed structure of human renal apatite interstitial and membrane-bound plaque, and explore the relationship to plaque apatite of osteopontin, a well-known and well-defined crystal-associated urine protein.
METHODS

Patients and materials
We studied deep medullary tissue from all 15 calcium oxalate stone-forming patients and four control nonstone-forming subjects we have previously reported [1] . For this work, we have focused on the details of plaque particle morphology and ultrastructure. Immunohistochemical techniques were used to study osteopontin localization in tissue from all 19 subjects. We present representative sections here, but have in all cases found similar patterns in the remaining cases.
Light microscopy
General. Human biopsy samples were taken during surgery and fixed in 5% fresh paraformaldehyde as previously reported [1] . Samples were dehydrated through graded ethanol concentrations to 100% ethanol and cleared in xylene before being embedded in a 50/50 mixture of Paraplast Xtra (Fisher Scientific, Itasca, IL, USA) and Peel-Away Micro-Cut (Polysciences Inc., Warrington, PA, USA). Ten serial sections were cut at 4 lm, placed on charged glass slides (Fisher Scientific) and stored at 4 • C. Half of the sections were stained with the Yasue metal substitution method for calcium histochemistry while the remaining slides were used for osteopontin immunolocalization. The Yasue method uses 5% aqueous silver nitrate and rubeanic acid to generate a dark brown to black histochemical staining of calcium deposits [10] .
Osteopontin immunolocalization. Osteopontin immunohistochemistry was preformed according to the peroxidase-antiperoxidase (PAP) method as we reported in our previous study [10] . The paraffin slides were deparaffinized and rehydrated through graded alcohols and blocked for nonspecific protein binding using 20% normal goat serum in 0.1 mol/L phosphate-buffered saline (PBS) at room temperature for 2 hours. The primary antibody was LFMb-14, a mouse monoclonal osteopontin antibody, a gift from Dr. Larry Fisher at NIH that was used at a 1:100 dilution, or mouse monoclonal 2A1. The secondary antibody was biotinylated goat antimouse IgG (Sigma Chemical Co., St. Louis, MO, USA). Reactivity was detected with the ELITE ABC kit (Vector Laboratories, Burlingame, CA, USA) and 3,3-diaminobezidine (DAB) tetrahydrochloride. DAB in Tris-HCl buffer was used as the chromogen. All sections were covered with DAB solution (0.05 mol/L Tris-HCl, 0.001% hydrogen peroxide, and 0.10% DAB), and incubated for approximately 10 minutes. Finally, each slide was rinsed well with buffer and lightly counterstained with hematoxylin. Controls were preformed with the elimination of the primary antibody and showed no staining.
Transmission electron microscopy (TEM)
Another set of 5 mm samples were taken during surgery, fixed in fresh 5% paraformaldehyde in phosphate buffer (pH 7.4) and divided in 1 mm blocks for either routine TEM or osteopontin immunoelectron microscopic analysis.
All tissue blocks used for routine TEM analysis were rinsed in phosphate buffer, dehydrated through a series of graded ethanol concentrations to 100% ethanol, passed through two changes of propylene oxide, and embedded in Epon 812 (Electron Microscopy Science, Ft. Washington, PA, USA). Thick sections (approximately 1 lm) were mounted on glass slides and stained with toluidine blue, whereas the thin sections (approximately 0.04 lm) were stained with uranyl acetate and lead citrate.
All tissue blocks used for immunoelectron microscopic analysis were dehydrated through series of graded ethanol concentrations to 100% ethanol, and embedded in Unicryl (Electron Microscopy Science). Thick sections (approximately 1 lm) were mounted on glass slides and stained with toluidine blue. Ultrathin sections were cut at 0.07 lm and placed on formvar/carbon coated 200 mesh nickel grids (Electron Microscopy Science). Each grid was then processed for immunogold labeling. Grids were floated on a drop of 0.05 mol/L glycine in PBS for 30 minutes to block residual aldehyde groups, followed by three rinses in PBS. To prevent nonspecific binding, grids were floated on a drop of blocking buffer [2% bovine serum albumin (BSA), 0.1% Cold Water Fish Gelatin, 0.1% Tween-20, and 8% sucrose in PBS] for 1 hour, then picked up and the edge touched to filter paper to wick off as much liquid as possible. Subsequently, the grids were incubated overnight at 4 • C in primary antibody diluted 1 to 100 in incubation buffer (0.1% BSA and 0.05% Tween-20 in PBS). Primary antibody was LFMb-14, a mouse monoclonal osteopontin antibody, a gift from Dr. Larry Fisher at NIH. Each grid was rinsed in three changes of the incubation buffer prior to incubation in secondary antibody. The secondary antibody was goat antimouse conjugated with 10 nm gold particles that had been conjugated to a universal secondary antibody Protein A (Electron Microscopy Science). Exposure to the secondary antibody was followed by postfixation in 2.5% glutaraldehyde in 0.1 mol/L phosphate buffer, and six rinses in distilled water. In order to visualize the cellular membranes, individual grids were floated on a drop of 1% osmium in distilled water and rinsed well. For contrast, grids were stained with uranyl acetate and lead citrate, rinsed and air dried in Petri dishes lined with filter paper.
All grids used for routine TEM and immunoelectron analysis were viewed with an FEI G2 Tecnai 12 BioTwin TEM (FEI, Hillsboro, OR, USA), equipped with an XR-60 Digital CCD system (AMT Corp., Danvers, MA, USA). 
RESULTS
Routine light and TEM
General plaque topography. Visualized by Yasue stain (Fig. 1A) , plaque deposits center about thin limbs (arrows) with little involvement of collecting ducts or vessels. In focal areas (asterisks) particles migrate into the surrounding interstitium, remaining in contiguity with the basement membrane of the thin limb ( Fig. 1B and C) . Gradual interstitial extension and enlargement appears in some regions (Fig. 1B) .
Basement membrane vs. interstitial plaque. In basement membranes, plaque particles are individual and laminated ( Fig. 2A ). Light regions within particles represent crystal, which we have already established as bio-logic apatite [1] . The electron-dense rings represent what we assume to be an organic layer based on prior studies of kidney stones [11, 12] . This figure is representative of all regions of basement membrane plaque. Even the smallest deposits have a central light region of crystal enveloped by organic material. Larger deposits have multiple alternating rings of crystal and organic layers (Fig. 2 ). Under high magnification TEM, the microcrystallite character of the solid phase is easily seen (Fig. 2B ).
In the interstitium, individual particles are not abundant. Instead particles are aggregated to form regions of attached particles, and in some regions what appears to be a fusion, or syncytium in which crystal islands float in an organic sea ( Fig. 3 ). Some regions of interstitial plaque are dominated by the syncytium pattern of the organic layer ( Fig. 3C and D) . In all regions, crystals are surrounded by a rim of organic material; it is the organic material that appears to form the continuous matrix in which crystals occur as more or less separate regions of limited size.
Regions of particle fusion. In many areas we can find extensive fields of individual particles that have aggregated together but remain identifiable as individual deposits ( Fig. 3A) . At high magnification, fusion of particles is demonstrated (Fig. 3B, arrows) . As well, fusion areas forming a syncytium are clearly seen ( Fig. 3C and D, arrow). We are concerned in this work with fusion of coated crystal particles and not with whether or not apatite crystal does or does not undergo aggregation. The specific behavior of the crystal phase itself would require studies other than those presented here.
Osteopontin immunolocalization
Light microscopy. In deep medulla of kidney from a normal human subject osteopontin antibody localizes in the cells of the inner medullary collecting ducts and thin loops of Henle ( Fig. 4A and B) . We have found this same exact pattern in three other normal subjects (not shown). In deep medulla from a calcium oxalate stone-forming patient ( Fig. 4C and D) osteopontin antibody localizes in the cells of collecting ducts and thin loops of Henle as in the normals. Intensity of cellular staining for osteopontin did not differ in stone formers vs. controls, or in areas with plaque vs. areas without plaque.
Osteopontin associates with plaque deposits as well as with cells ( Fig. 4C and D) . Plaque deposits stained with the Yasue stain are shown in a serial section (Fig. 4E ) so the relationship between osteopontin and plaque localization can be visualized (compare Fig. 4D and E) . This pattern of colocalization of osteopontin antibody and interstitial apatite plaque was seen in deep medulla from all 15 calcium oxalate stone-forming patients (remainder of patients not shown).
TEM. Osteopontin immunogold label in thin loop basement membrane specifically localizes to individual plaque particles ( Fig. 5 ). Within individual crystalline particles ( Fig. 5B and C) , the osteopontin immunogold particles align themselves mainly on the surfaces of the apatite crystal phase, at the junction of the crystal and its organic coating layer. At higher resolution (Fig. 5D ) this specific localization is particularly clear. What we show in these examples is representative of all sections thus far studied.
The osteopontin immunogold label in the interstitium shows a similar pattern. Within particle aggregates, osteopontin immunogold label often aligns closely with the crystal organic interfacial regions, conforming to the irregular outlines of the apatite phases ( Fig. 6 ). Within syncytial regions ( Fig. 6A and B ) immunogold particles associate strongly with the islands of apatite phase; few immunogold particles can be seen in regions devoid of apatite. At high resolution ( Fig. 6C and D) , areas of apatite crystal are surrounded by osteopontin immunogold label, forming in some cases a double layer of immunogold particles around a ring of apatite crystal (arrows). 
DISCUSSION
Formation and extension of plaque
We have already presented evidence that plaque originates in the basement membranes of the thin limbs [1] . This is the only region that always contains plaque when any plaque is present, and the only region in which one repeatedly finds plaque in isolation. At no time have we ever found apatite crystals in the lumens of healthy thin limbs whose basement membranes contain plaque, so we have been forced to assume that plaque forms in the membranes, rather than that apatite crystals form in the thin loop lumens and migrate into the membranes. Here we show for the first time evidence for extension of plaque articles into the interstitium to form masses of interstitial plaque that have contiguity with the thin limb basement membranes.
The fact of the contiguity forces us to presume that either the plaque has formed simultaneously in the basement membranes and interstitium, or has migrated by extension from basement membrane into the interstitium. Simultaneous formation is not attractive in that we often find basement membrane plaque without surrounding interstitial plaque but never the converse. Formation in the interstitium and migration into the membrane is even less acceptable in that we have never observed interstitial plaque in contiguity with basement membranes devoid of plaque whereas we regularly find plaque in basement membranes whose surrounding interstitium is devoid of plaque. This leaves us with membrane plaque formation Fig. 4. Light microscopic osteopontin staining in papillary biopsies from control (A and B) and calcium oxalate stone formers (C to E). (A) The control tissue without the primary antibody while (B) is with the osteopontin antibody showing staining of the inner medullary collecting ducts (arrow) and thin loops of Henle (double arrow). A set of serial sections of a calcium oxalate stone former (C to E). (C) The calcium oxalate tissue without the primary antibody while the tissue in (D) is stained with the osteopontin antibody. Osteopontin is localized to inner medullary collecting ducts (arrows) and thin loops of Henle (double arrows) as well as sites of crystal deposition ( * ). (E) A serial section of the calcium oxalate patient that has been stained with the Yasue method and shows positive sites (black to brown stain) of crystalline material that can be correlated with osteopontin positive sites [magnification, ×600 (A); ×600 (B); ×60 (C); ×60 (D); and ×60 (E)]. and subsequent extension into interstitium as our primary working hypothesis, but does not exclude simultaneous formation in interstitium and basement membrane.
Basement membrane vs. interstitial plaque
The morphologies of plaque in membrane and interstitium appear to favor membrane formation with subsequent interstitial migration. In thin limb membranes plaque is always particulate, whereas in the interstitium it varies from aggregates of plaque particles to a complete syncytium. We have presented evidence that particles clearly fuse in pairs and higher groups to form aggregates and the syncytium. Therefore, the most reasonable provisional hypothesis is that in the regions of contiguity we have shown here particles are moving out of the basement membranes, and fusing in the interstitium to form the interstitial plaque configuration. We are unaware of any prior demonstrations of the plaque ultrastructure presented here.
The specific mechanisms of account for how particles appear to extend into the renal interstitium are not known. We can envision four alternatives. Individual particles could physically migrate into the interstitium perhaps by Brownian motion. Interstitial cells or possibly migrating monocytes might take particles up and move them. We have seen evidence for this. The interstitial cells could create nucleating conditions with de novo forma-tion of interstitial particle aggregates. Finally, crystal mass within a region of basement membrane could enlarge and physically extend by direct contiguity into the interstitium. At the present time we cannot distinguish these, but some of the micrographs support the last alternative.
Osteopontin
In the absence of plaque we have demonstrated deep medulla osteopontin localization in the cells of thin limbs and collecting ducts. A prior report [13] that did not have extensive deep medulla tissue describes staining of occasional collecting duct cells but does not comment on thin limbs. This report may well be the first concerning osteopontin in deep medulla of healthy humans. In normal rats, the pattern varies with the antibody employed but thin limb and papillary epithelium are usual sites of localization [14] .
Osteopontin expression is up-regulated by many forms of renal injury that have nothing to do with crystal forma-tion [14, 15] . These include renal injury from drugs, hypertension, obstruction, ischemia, and glomerulonephritis. We did not find increased osteopontin in renal cells adjacent to plaque particles compared to cells in areas free of plaque particles, nor was cell osteopontin staining increased in tissue from the stone formers compared to tissue from our controls. Therefore, at least this gauge of renal injury did not suggest that plaque injures renal cells.
In areas of deep medulla that contain plaque, osteopontin localizes strongly to plaque areas. Within these areas, we find the antibody localizes specifically to the surfaces of the apatite crystal. In plaque particles within basement membranes, or areas of apatite in the interstitial plaque syncytium, osteopontin localizes at the interface between the apatite crystal phase and its surrounding organic coating.
The affinity of osteopontin for apatite crystals is well documented [12] . It is found in bone matrix in association with bone mineral apatite [16] . It is associated with mineral phases in pathologic vessel calcifications [17] . It is found in the matrix of kidney stones [12] . It is an established urinary inhibitor of calcium oxalate and calcium phosphate crystallization [5, 18, 19] . In an osteopontin knockout mouse given ethylene glycol to induce oxalate production, calcium oxalate crystal formation was enhanced compared to the wild-type mouse [20] . In mice lacking the sodium phosphate cotransporter gene Npt2 apatite crystals form in tubule lumens, and osteopontin localizes primarily on the surfaces of apatite crystal deposits [21] . Given what is known, it is not surprising that we find this molecule localized at the apatite crystal surface.
What role the molecule plays in plaque pathogenesis is at present unknown. We presume its source is at least from the cells of the thin limbs. It may simply adsorb to apatite crystal surfaces of plaque and play no other role. However, it is known to inhibit apatite crystal growth [18, 22] and could be important in limiting the amount of apatite crystal formed. Exogenous osteopontin limited the extent of apatite formation in cultured bovine smooth muscle cells [23] . On the other hand, when immobilized, osteopontin can nucleate hydroxyapatite crystallization [24] . Possibly both occur.
Implications for pathogenesis of calcium oxalate stones
If indeed we accept the general hypothesis that apatite plaque may be an anchored site on which calcium oxalate stones form and grow, the present work makes clear that it is unlikely that the surface of plaque presented to the final urine will be apatite crystal per se. We find all apatite crystal in plaque is surrounded by an organic layer whose composition is not presently known. It is this material that is most likely to face the final urine. We did not find osteopontin particularly located on the outer surface of the organic layers of individual plaque particles in basement membranes. In the interstitial plaque syncytium we found osteopontin adsorbed to apatite, which is within the organic material. Therefore, we are not able to say that osteopontin is likely to face the final urine. Clearly the nature of the organic layers of plaque is critical to an understanding of what role plaque might play in calcium oxalate stone genesis.
